Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparative Effectiveness of Pregnancy Failure Management Regimens

Next Previous
X
Search
Trial Profile

Comparative Effectiveness of Pregnancy Failure Management Regimens

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 May 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mifepristone (Primary) ; Misoprostol
  • Indications Induced abortion
  • Focus Therapeutic Use
  • Acronyms PreFaiR

    • Most Recent Events

    • 27 Apr 2021 Results of secondary analysis of this study comparing participant-reported bleeding and pain with two medication regimens for early pregnancy loss, published in the Contraception.
    • 03 Dec 2020 Results assessing relationship between race and depression symptoms among participants in an early pregnancy loss clinical trial published in the Obstetrics and Gynecology
    • 16 Apr 2020 Results of planned secondary analysis evaluating clinical predictors previously associated with single dose vaginal misoprostol treatment success, published in the American Journal of Obstetrics and Gynecology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top